Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.8800
-0.0320 (-3.51%)
At close: Jun 5, 2025, 4:00 PM
0.8611
-0.0189 (-2.15%)
After-hours: Jun 5, 2025, 6:55 PM EDT

Pasithea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
7481939-
Market Cap Growth
-53.47%-48.26%-58.92%-51.55%--
Enterprise Value
1-5-11-2318-
Last Close Price
0.913.157.4012.8335.40-
PS Ratio
----2572.20-
PB Ratio
0.190.270.330.440.75-
P/TBV Ratio
1.490.640.540.570.75-
EV/Sales Ratio
----1206.82-
Debt / Equity Ratio
--0.000.01--
Asset Turnover
----0.00-
Quick Ratio
3.356.186.2217.62118.4236.90
Current Ratio
3.846.586.3418.15119.1737.55
Return on Equity (ROE)
-82.81%-72.84%-47.07%-24.97%-8.41%-
Return on Assets (ROA)
-46.84%-42.23%-28.02%-15.98%-10.52%-
Return on Capital (ROIC)
-52.78%-46.55%-30.04%-16.67%-10.91%-
Earnings Yield
-200.44%-348.55%-207.04%-74.25%-5.61%-
FCF Yield
-186.46%-349.02%-174.58%-73.52%-8.25%-
Buyback Yield / Dilution
-19.54%10.64%2.83%-142.65%-41.29%-
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q